The Bonnie J. Addario Lung Cancer Foundation
The Lung Cancer Foundation's

LungBlog

An up-to-the-minute dose of health and hope for lung cancer

Bonnie Addario in UCSF Lab
 

OSI Pharma Cancer Drug Gets OK in Japan

tarceva.jpgOSI Pharmaceuticals Inc. said Monday its lung cancer drug Tarceva received regulatory approvals in Japan.

This entry was posted on Monday, October 22nd, 2007 at 8:28 am and is filed under Research, Treatment. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

« Publicist: Wagoner Has Lung Cancer
Thalomid® May not Improve Outcomes of Patients with Small-Cell Lung Cancer (SCLC) »

Leave a Reply